Synergy Pharmaceuticals (SGYP) Stock Higher in After-Hours Trading Following Paulson Investment

NEW YORK (TheStreet) -- Synergy Pharmaceuticals (SGYP) shares continue to climb in after-hours trading today, up 1.03% to $3.93, following reports that John Paulson's Paulson & Co. hedge fund took a position in the gastrointestinal biopharmaceutical company.

Synergy Pharmaceuticals stock closed intraday trading up 10.51% to $3.89 on Monday after Paulson disclosed that it had purchased about 2.1 million shares of the company, a 2.1% stake valued at about $8.3 million.

The purchase makes Paulson the fifth largest shareholder of the New York City-based drug manufacturer.

SGYP Chart SGYP data by YCharts

If you liked this article you might like

Winning FDA Approval Isn't Always a Win

Will Allergan's Deal With Tribe Hold Up?

2 Small Biotechs Under $5 May Be Bargains

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)

3 Biotech Stocks on Readers' Minds